Jun 21 |
Baird sees Jazz study failure as positive for rival Praxis
|
Jun 21 |
Praxis Precision Medicines (PRAX) Surges 6.4%: Is This an Indication of Further Gains?
|
Jun 20 |
Jazz Dives — And Takes Praxis With It — On Essential Tremor Drug Failure
|
May 30 |
This Is Why Praxis Precision Medicines, Inc.'s (NASDAQ:PRAX) CEO Compensation Looks Appropriate
|
May 17 |
Praxis Precision Medicines to Participate in Upcoming Investor Conferences
|
May 14 |
We're Hopeful That Praxis Precision Medicines (NASDAQ:PRAX) Will Use Its Cash Wisely
|
May 13 |
Praxis Precision Medicines GAAP EPS of -$2.84 misses by $0.75, revenue of $0.43M misses by $1.33M
|
May 13 |
Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2024 Financial Results
|
May 10 |
Praxis Precision Medicines to Report First Quarter 2024 Financial Results on Monday, May 13, 2024
|
May 2 |
Wall Street Analysts See a 144.74% Upside in Praxis Precision Medicines (PRAX): Can the Stock Really Move This High?
|